Company Filing History:
Years Active: 2014
Title: Hyunjung Kim: Innovator in Cyclopentaquinazoline Synthesis
Introduction
Hyunjung Kim is a prominent inventor based in Collegeville, PA (US). She has made significant contributions to the field of chemistry, particularly in the synthesis of cyclopentaquinazolines. Her innovative work has led to advancements in the production of enantiomerically enriched compounds.
Latest Patents
Hyunjung Kim holds a patent for the "Synthesis of cyclopentaquinazolines." This patent describes a method for producing 6-amino-cyclopenta[g]quinazolines in an enantiomerically enriched form. The method is particularly applicable to the synthesis of N—{N-{4-[N-((6S)-2-hydroxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclo-penta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L-γ-glutamyl}-D-glutamic acid (ONX-0801). This innovation showcases her expertise in complex chemical synthesis.
Career Highlights
Hyunjung Kim is associated with Onyx Pharmaceuticals, Inc., where she applies her knowledge and skills in pharmaceutical research and development. Her work has been instrumental in advancing the company's research initiatives.
Collaborations
Throughout her career, Hyunjung has collaborated with notable colleagues, including James Alan Kerschen and Alexander James Bridges. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Hyunjung Kim's contributions to the field of chemistry, particularly in the synthesis of cyclopentaquinazolines, highlight her role as an influential inventor. Her work continues to impact the pharmaceutical industry positively.